Medical Devices & Consumables
Global Class Ⅱ AI Medical Imaging Software Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 558155
- Pages: 117
- Figures: 125
- Views: 10
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Class Ⅱ AI Medical Imaging Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Yizhun Intelligent
Deepwise
Fosun Aitrox
Shukun Technology
Infervision Medical
Airdoc
Diagens Biotechnology
Segment by Type
Cardiovascular
Pulmonary
Cerebral
Others
Segment by Application
Hospital
Clinic
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Class Ⅱ AI Medical Imaging Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Class Ⅱ AI Medical Imaging Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Yizhun Intelligent
Deepwise
Fosun Aitrox
Shukun Technology
Infervision Medical
Airdoc
Diagens Biotechnology
Segment by Type
Cardiovascular
Pulmonary
Cerebral
Others
Segment by Application
Hospital
Clinic
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Class Ⅱ AI Medical Imaging Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Class Ⅱ AI Medical Imaging Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cardiovascular
1.2.3 Pulmonary
1.2.4 Cerebral
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Class Ⅱ AI Medical Imaging Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Class Ⅱ AI Medical Imaging Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Class Ⅱ AI Medical Imaging Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Class Ⅱ AI Medical Imaging Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cardiovascular Market Size by Players
3.3.2 Pulmonary Market Size by Players
3.3.3 Cerebral Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Class Ⅱ AI Medical Imaging Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Class Ⅱ AI Medical Imaging Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Class Ⅱ AI Medical Imaging Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
6.4 North America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Class Ⅱ AI Medical Imaging Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
7.4 Europe Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Class Ⅱ AI Medical Imaging Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
9.4 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Yizhun Intelligent
11.1.1 Yizhun Intelligent Corporation Information
11.1.2 Yizhun Intelligent Business Overview
11.1.3 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.1.4 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.1.5 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.1.6 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.1.7 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.1.8 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.1.9 Yizhun Intelligent Recent Developments
11.2 Deepwise
11.2.1 Deepwise Corporation Information
11.2.2 Deepwise Business Overview
11.2.3 Deepwise Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.2.4 Deepwise Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.2.5 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.2.6 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.2.7 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.2.8 Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.2.9 Deepwise Recent Developments
11.3 Fosun Aitrox
11.3.1 Fosun Aitrox Corporation Information
11.3.2 Fosun Aitrox Business Overview
11.3.3 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.3.4 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.3.5 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.3.6 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.3.7 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.3.8 Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.3.9 Fosun Aitrox Recent Developments
11.4 Shukun Technology
11.4.1 Shukun Technology Corporation Information
11.4.2 Shukun Technology Business Overview
11.4.3 Shukun Technology Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.4.4 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.4.5 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.4.6 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.4.7 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.4.8 Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.4.9 Shukun Technology Recent Developments
11.5 Infervision Medical
11.5.1 Infervision Medical Corporation Information
11.5.2 Infervision Medical Business Overview
11.5.3 Infervision Medical Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.5.4 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.5.5 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.5.6 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.5.7 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.5.8 Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.5.9 Infervision Medical Recent Developments
11.6 Airdoc
11.6.1 Airdoc Corporation Information
11.6.2 Airdoc Business Overview
11.6.3 Airdoc Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.6.4 Airdoc Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.6.5 Airdoc Recent Developments
11.7 Diagens Biotechnology
11.7.1 Diagens Biotechnology Corporation Information
11.7.2 Diagens Biotechnology Business Overview
11.7.3 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.7.4 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.7.5 Diagens Biotechnology Recent Developments
12 Class Ⅱ AI Medical Imaging SoftwareIndustry Chain Analysis
12.1 Class Ⅱ AI Medical Imaging Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Class Ⅱ AI Medical Imaging Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Class Ⅱ AI Medical Imaging Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Class Ⅱ AI Medical Imaging Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cardiovascular
1.2.3 Pulmonary
1.2.4 Cerebral
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Class Ⅱ AI Medical Imaging Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Class Ⅱ AI Medical Imaging Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Class Ⅱ AI Medical Imaging Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Class Ⅱ AI Medical Imaging Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cardiovascular Market Size by Players
3.3.2 Pulmonary Market Size by Players
3.3.3 Cerebral Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Class Ⅱ AI Medical Imaging Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Class Ⅱ AI Medical Imaging Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Class Ⅱ AI Medical Imaging Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
6.4 North America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Class Ⅱ AI Medical Imaging Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
7.4 Europe Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Class Ⅱ AI Medical Imaging Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
9.4 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Yizhun Intelligent
11.1.1 Yizhun Intelligent Corporation Information
11.1.2 Yizhun Intelligent Business Overview
11.1.3 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.1.4 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.1.5 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.1.6 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.1.7 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.1.8 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.1.9 Yizhun Intelligent Recent Developments
11.2 Deepwise
11.2.1 Deepwise Corporation Information
11.2.2 Deepwise Business Overview
11.2.3 Deepwise Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.2.4 Deepwise Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.2.5 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.2.6 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.2.7 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.2.8 Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.2.9 Deepwise Recent Developments
11.3 Fosun Aitrox
11.3.1 Fosun Aitrox Corporation Information
11.3.2 Fosun Aitrox Business Overview
11.3.3 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.3.4 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.3.5 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.3.6 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.3.7 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.3.8 Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.3.9 Fosun Aitrox Recent Developments
11.4 Shukun Technology
11.4.1 Shukun Technology Corporation Information
11.4.2 Shukun Technology Business Overview
11.4.3 Shukun Technology Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.4.4 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.4.5 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.4.6 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.4.7 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.4.8 Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.4.9 Shukun Technology Recent Developments
11.5 Infervision Medical
11.5.1 Infervision Medical Corporation Information
11.5.2 Infervision Medical Business Overview
11.5.3 Infervision Medical Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.5.4 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.5.5 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024
11.5.6 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024
11.5.7 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024
11.5.8 Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis
11.5.9 Infervision Medical Recent Developments
11.6 Airdoc
11.6.1 Airdoc Corporation Information
11.6.2 Airdoc Business Overview
11.6.3 Airdoc Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.6.4 Airdoc Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.6.5 Airdoc Recent Developments
11.7 Diagens Biotechnology
11.7.1 Diagens Biotechnology Corporation Information
11.7.2 Diagens Biotechnology Business Overview
11.7.3 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Product Features and Attributes
11.7.4 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)
11.7.5 Diagens Biotechnology Recent Developments
12 Class Ⅱ AI Medical Imaging SoftwareIndustry Chain Analysis
12.1 Class Ⅱ AI Medical Imaging Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Class Ⅱ AI Medical Imaging Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Class Ⅱ AI Medical Imaging Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Class Ⅱ AI Medical Imaging Software Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Class Ⅱ AI Medical Imaging Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Class Ⅱ AI Medical Imaging Software as of 2024)
Table 11. Global Class Ⅱ AI Medical Imaging Software Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Class Ⅱ AI Medical Imaging Software Companies Headquarters
Table 13. Global Class Ⅱ AI Medical Imaging Software Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2026-2031) & (US$ Million)
Table 21. Class Ⅱ AI Medical Imaging Software High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 25. North America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 27. Europe Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges
Table 31. Central and South America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Yizhun Intelligent Corporation Information
Table 35. Yizhun Intelligent Description and Major Businesses
Table 36. Yizhun Intelligent Product Features and Attributes
Table 37. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Yizhun Intelligent Revenue Proportion by Product in 2024
Table 39. Yizhun Intelligent Revenue Proportion by Application in 2024
Table 40. Yizhun Intelligent Revenue Proportion by Geographic Area in 2024
Table 41. Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 42. Yizhun Intelligent Recent Developments
Table 43. Deepwise Corporation Information
Table 44. Deepwise Description and Major Businesses
Table 45. Deepwise Product Features and Attributes
Table 46. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Deepwise Revenue Proportion by Product in 2024
Table 48. Deepwise Revenue Proportion by Application in 2024
Table 49. Deepwise Revenue Proportion by Geographic Area in 2024
Table 50. Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 51. Deepwise Recent Developments
Table 52. Fosun Aitrox Corporation Information
Table 53. Fosun Aitrox Description and Major Businesses
Table 54. Fosun Aitrox Product Features and Attributes
Table 55. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Fosun Aitrox Revenue Proportion by Product in 2024
Table 57. Fosun Aitrox Revenue Proportion by Application in 2024
Table 58. Fosun Aitrox Revenue Proportion by Geographic Area in 2024
Table 59. Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 60. Fosun Aitrox Recent Developments
Table 61. Shukun Technology Corporation Information
Table 62. Shukun Technology Description and Major Businesses
Table 63. Shukun Technology Product Features and Attributes
Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Shukun Technology Revenue Proportion by Product in 2024
Table 66. Shukun Technology Revenue Proportion by Application in 2024
Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024
Table 68. Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 69. Shukun Technology Recent Developments
Table 70. Infervision Medical Corporation Information
Table 71. Infervision Medical Description and Major Businesses
Table 72. Infervision Medical Product Features and Attributes
Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Infervision Medical Revenue Proportion by Product in 2024
Table 75. Infervision Medical Revenue Proportion by Application in 2024
Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024
Table 77. Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 78. Infervision Medical Recent Developments
Table 79. Airdoc Corporation Information
Table 80. Airdoc Description and Major Businesses
Table 81. Airdoc Product Features and Attributes
Table 82. Airdoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Airdoc Recent Developments
Table 84. Diagens Biotechnology Corporation Information
Table 85. Diagens Biotechnology Description and Major Businesses
Table 86. Diagens Biotechnology Product Features and Attributes
Table 87. Diagens Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Diagens Biotechnology Recent Developments
Table 89. Raw Materials Key Suppliers
Table 90. Distributors List
Table 91. Market Trends and Market Evolution
Table 92. Market Drivers and Opportunities
Table 93. Market Challenges, Risks, and Restraints
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Class Ⅱ AI Medical Imaging Software Product Picture
Figure 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cardiovascular Product Picture
Figure 4. Pulmonary Product Picture
Figure 5. Cerebral Product Picture
Figure 6. Others Product Picture
Figure 7. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Class Ⅱ AI Medical Imaging Software Report Years Considered
Figure 11. Global Class Ⅱ AI Medical Imaging Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 13. Global Class Ⅱ AI Medical Imaging Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Region (2020-2031)
Figure 15. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Cardiovascular Revenue Market Share by Player in 2024
Figure 18. Pulmonary Revenue Market Share by Player in 2024
Figure 19. Cerebral Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Type (2020-2031)
Figure 22. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Application (2020-2031)
Figure 23. North America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 25. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 32. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 35. France Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 47. India Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 55. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 61. South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 67. Class Ⅱ AI Medical Imaging Software Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Class Ⅱ AI Medical Imaging Software Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Class Ⅱ AI Medical Imaging Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Class Ⅱ AI Medical Imaging Software as of 2024)
Table 11. Global Class Ⅱ AI Medical Imaging Software Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Class Ⅱ AI Medical Imaging Software Companies Headquarters
Table 13. Global Class Ⅱ AI Medical Imaging Software Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2026-2031) & (US$ Million)
Table 21. Class Ⅱ AI Medical Imaging Software High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 25. North America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 27. Europe Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges
Table 31. Central and South America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Yizhun Intelligent Corporation Information
Table 35. Yizhun Intelligent Description and Major Businesses
Table 36. Yizhun Intelligent Product Features and Attributes
Table 37. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Yizhun Intelligent Revenue Proportion by Product in 2024
Table 39. Yizhun Intelligent Revenue Proportion by Application in 2024
Table 40. Yizhun Intelligent Revenue Proportion by Geographic Area in 2024
Table 41. Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 42. Yizhun Intelligent Recent Developments
Table 43. Deepwise Corporation Information
Table 44. Deepwise Description and Major Businesses
Table 45. Deepwise Product Features and Attributes
Table 46. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Deepwise Revenue Proportion by Product in 2024
Table 48. Deepwise Revenue Proportion by Application in 2024
Table 49. Deepwise Revenue Proportion by Geographic Area in 2024
Table 50. Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 51. Deepwise Recent Developments
Table 52. Fosun Aitrox Corporation Information
Table 53. Fosun Aitrox Description and Major Businesses
Table 54. Fosun Aitrox Product Features and Attributes
Table 55. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Fosun Aitrox Revenue Proportion by Product in 2024
Table 57. Fosun Aitrox Revenue Proportion by Application in 2024
Table 58. Fosun Aitrox Revenue Proportion by Geographic Area in 2024
Table 59. Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 60. Fosun Aitrox Recent Developments
Table 61. Shukun Technology Corporation Information
Table 62. Shukun Technology Description and Major Businesses
Table 63. Shukun Technology Product Features and Attributes
Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Shukun Technology Revenue Proportion by Product in 2024
Table 66. Shukun Technology Revenue Proportion by Application in 2024
Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024
Table 68. Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 69. Shukun Technology Recent Developments
Table 70. Infervision Medical Corporation Information
Table 71. Infervision Medical Description and Major Businesses
Table 72. Infervision Medical Product Features and Attributes
Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Infervision Medical Revenue Proportion by Product in 2024
Table 75. Infervision Medical Revenue Proportion by Application in 2024
Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024
Table 77. Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis
Table 78. Infervision Medical Recent Developments
Table 79. Airdoc Corporation Information
Table 80. Airdoc Description and Major Businesses
Table 81. Airdoc Product Features and Attributes
Table 82. Airdoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Airdoc Recent Developments
Table 84. Diagens Biotechnology Corporation Information
Table 85. Diagens Biotechnology Description and Major Businesses
Table 86. Diagens Biotechnology Product Features and Attributes
Table 87. Diagens Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Diagens Biotechnology Recent Developments
Table 89. Raw Materials Key Suppliers
Table 90. Distributors List
Table 91. Market Trends and Market Evolution
Table 92. Market Drivers and Opportunities
Table 93. Market Challenges, Risks, and Restraints
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Class Ⅱ AI Medical Imaging Software Product Picture
Figure 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cardiovascular Product Picture
Figure 4. Pulmonary Product Picture
Figure 5. Cerebral Product Picture
Figure 6. Others Product Picture
Figure 7. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Class Ⅱ AI Medical Imaging Software Report Years Considered
Figure 11. Global Class Ⅱ AI Medical Imaging Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 13. Global Class Ⅱ AI Medical Imaging Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Region (2020-2031)
Figure 15. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Cardiovascular Revenue Market Share by Player in 2024
Figure 18. Pulmonary Revenue Market Share by Player in 2024
Figure 19. Cerebral Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Type (2020-2031)
Figure 22. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Application (2020-2031)
Figure 23. North America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 25. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 32. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 35. France Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 47. India Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 55. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024
Figure 61. South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)
Figure 67. Class Ⅱ AI Medical Imaging Software Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232